Form 4: STAAR Surgical COO Warren Foust Reports Stock Transaction
SEC Form 4 Filing
Warren Foust, COO of STAAR Surgical, reports the disposition of shares to cover tax obligations following the vesting of restricted stock units.
Summary
- On May 8, 2024, Warren Foust, the Chief Operating Officer of STAAR Surgical Co., reported a transaction involving the company's stock.
- The transaction involved the disposition of 2,418 shares of common stock at a price of $41.02 per share to satisfy tax obligations related to the vesting of restricted stock units (RSUs).
- Following the transaction, Foust beneficially owns 17,913 shares of STAAR Surgical Co.
- The RSUs were granted on May 8, 2023, and vest in three annual installments.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of stock transactions by a company officer, with no inherent positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine sale of shares to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 05/08/2023 | Date of grant for 20,331 restricted stock units (RSUs) vesting over three years. |
| 05/08/2024 | RSUs vested as to 6,777 shares; 2,418 shares were withheld to satisfy taxes. |
| 05/09/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.